Central venous catheter-related blood stream infection (CRBSI) is a major cause of morbidity and mortality in patients with end-stage renal disease treated with chronic hemodialysis. Risk factors ...

Hemodialysis catheters are catheters that provide temporary vascular access for hemodialysis until a permanent access is available or until another type of dialysis therapy is substituted.

Before 1998, urokinase was considered standard therapy for the management of occluded hemodialysis catheters. The dose of 5000 units per port appears on the FDA-approved labeling for urokinase.

Researchers have found in a new study that the occurrence of inflow pain and drain pain following peritoneal dialysis ...

The effectiveness of alteplase and urokinase in restoring adequate hemodialysis blood-flow rates was examined. A retrospective review of the medical records of hemodialysis patients with central ...

Use of high-dose (46.7%) sodium citrate locks for central venous catheters (CVCs) being used for maintenance hemodialysis provides no advantage over 5% heparin locks in reducing infections or ...

The conventional surgery for removal of Continuous Peritoneal Dialysis catheter is similar to open insertion technique and requires the surgeon to either go through the same incision or make a ...

In 2023, the catheter market is projected to surge to a size of around USD 12,591.30 million. In the forecast period from ...

The study, published in Kidney360, found that patients on home hemodialysis had a 42% lower risk of stroke, 17% lower risk of acute coronary syndrome, 22% lower risk of cardiovascular death and 8% ...